SNY vs. NVO
SNY (Sanofi) and NVO (Novo Nordisk A/S) are both stocks. Both operate in the Drug Manufacturers - General industry within the Healthcare sector. Over the past 10 years, SNY returned 4.59%/yr vs 7.55%/yr for NVO. Their 0.38 correlation means their historical movements had little consistent relationship.
Performance
SNY vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SNY achieves a -6.17% return, which is significantly lower than NVO's -4.23% return. Over the past 10 years, SNY has underperformed NVO with an annualized return of 4.59%, while NVO has yielded a comparatively higher 7.55% annualized return.
SNY
- 1D
- 0.44%
- 1M
- -0.19%
- 6M
- -3.34%
- YTD
- -6.17%
- 1Y
- -2.74%
- 3Y*
- -2.29%
- 5Y*
- 0.72%
- 10Y*
- 4.59%
- ALL TIME*
- 5.30%
NVO
- 1D
- -8.78%
- 1M
- -6.64%
- 6M
- -18.01%
- YTD
- -4.23%
- 1Y
- 2.25%
- 3Y*
- -14.32%
- 5Y*
- 2.48%
- 10Y*
- 7.55%
- ALL TIME*
- 14.37%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $504.41M | $480.49M | $577.88M | |
SNY Sanofi | $172.97M | $151.05M | $146.29M |
SNY vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | -6.17% | 4.93% | 1.09% | 6.55% | 0.57% | 7.00% | 0.39% | 20.47% | 6.06% | 9.96% |
NVO Novo Nordisk A/S | -4.23% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between SNY and NVO is 0.19, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.19 |
Correlation (3Y) Balances recent behavior with more history. | 0.26 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.30 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.36 |
Correlation (All Time) Calculated using the full available price history since Jul 1, 2002 | 0.38 |
The correlation between SNY and NVO shifts across timeframes, from 0.19 (1 year) to 0.38 (all time), reflecting how their relationship changes across market environments.
Fundamentals
SNY:
$103.44B
NVO:
$209.19B
SNY:
€1.63
NVO:
DKK 27.42
SNY:
22.94
NVO:
11.15
SNY:
2.11
NVO:
0.48
SNY:
1.86
NVO:
4.15
SNY:
1.29
NVO:
6.70
SNY:
€48.92B
NVO:
DKK 327.80B
SNY:
€35.72B
NVO:
DKK 268.30B
SNY:
€12.41B
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SNY vs. NVO — Risk / Return Rank
SNY
NVO
SNY vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SNY | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.12 | ||
| Sortino ratioReturn per unit of downside risk | -0.31 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 1.06 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | -0.02 | 0.11 | -0.13 |
| Martin ratioReturn relative to average drawdown | -0.04 | 0.20 | -0.23 |
Loading charts...
Drawdowns
SNY vs. NVO - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.46%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for SNY and NVO.
Loading charts...
Drawdown Indicators
| SNY | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.46% | -74.70% | +28.24% |
Max Drawdown (1Y)Largest decline over 1 year | -16.70% | -43.67% | +26.97% |
Max Drawdown (3Y)Largest decline over 3 years | -23.37% | -74.70% | +51.33% |
Max Drawdown (5Y)Largest decline over 5 years | -33.52% | -74.70% | +41.18% |
Max Drawdown (10Y)Largest decline over 10 years | -33.52% | -74.70% | +41.18% |
Current DrawdownCurrent decline from peak | -20.08% | -65.79% | +45.71% |
Average DrawdownAverage peak-to-trough decline | -12.24% | -17.93% | +5.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.59% | 23.97% | -14.38% |
Volatility
SNY vs. NVO - Volatility Comparison
The current volatility for Sanofi (SNY) is 8.66%, while Novo Nordisk A/S (NVO) has a volatility of 12.28%. This indicates that SNY experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SNY | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.66% | 12.28% | -3.62% |
Volatility (6M)Calculated over the trailing 6-month period | 17.58% | 36.87% | -19.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.74% | 46.77% | -20.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.17% | 38.76% | -13.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.49% | 32.76% | -9.27% |
Dividends
SNY vs. NVO - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 5.62%, more than NVO's 3.83% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 3.83% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
SNY Sanofi | 5.62% | 4.56% | 4.22% | 3.83% | 4.32% | 3.80% | 3.61% | 3.47% | 4.29% | 3.82% | 4.11% | 3.77% |
Financials
SNY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SNY vs. NVO - Profitability Comparison
SNY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Sanofi reported a gross profit of 9.28B and revenue of 12.30B. Therefore, the gross margin over that period was 75.5%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
SNY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Sanofi reported an operating income of 2.38B and revenue of 12.30B, resulting in an operating margin of 19.4%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
SNY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Sanofi reported a net income of 343.00M and revenue of 12.30B, resulting in a net margin of 2.8%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
SNY and NVO have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (12.28%) compared to SNY (8.66%). In terms of maximum drawdown, SNY dropped -46.46% vs NVO's -74.70%.
NVO currently has the higher Sharpe Ratio (0.10 vs -0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SNY and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer